Mechanism of resistance to novel targeted therapy for ovarian cancer identified
Wednesday, October 10, 2018 - 00:40
in Biology & Nature
Scientists have unraveled a mechanism of resistance to EZH2 inhibitors in ovarian cancers with mutations in the ARID1A gene.